March 14, 2011 09:16 ET

Equity Research on Stryker Corporation and Boston Scientific Corporation - Medical Instrument Makers Restructuring and Acquiring

NEW YORK CITY, NY--(Marketwire - March 14, 2011) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the medical instruments & supplies industry and are offering free analytical research on Stryker Corporation (NYSE: SYK) and Boston Scientific Corporation (NYSE: BSX). Register with us today at to have free access to this research and speak to one of our pros.

Device recalls have led to market share declines for several medical instrument makers. The ground lost to competitors has also put the acquisition cross hairs on many device makers and will be well worth tracking this year. Lost revenues are also leading to restructuring efforts. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future. is the Ultimate Trading Environment for investors. If you are considering owning Stryker Corporation and Boston Scientific Corporation then you should sign up for a free membership and our complimentary reports today at Over the last 5 years our returns outpaced any of the major indexes. Shine's performance in 2005 was +14%, 2006 + 26%, 2007 +99%, 2008 + 355% and 2009 + 46%. Sign up today to find out what you are missing.

Getting devices to market amidst greater regulatory pressure from the Food and Drug Administration has also partially led to acquisition activity. Boston Scientific Corp.'s acquisition of Atritech and Sadra Medical were both positive steps towards strengthening the company's product portfolio. Boston Scientific Corporation report is accessible for free by registering today at

Greater competition has also made improving operating efficiency increasingly important. Some companies are narrowing their focus onto fewer divisions and markets to accomplish this. Boston Scientific's sale of its neurovascular division to Stryker Corp. for $1.5 billion reflects both the ongoing streamlining and acquisition trends seen throughout the industry. Stryker Corporation report is accessible for free by registering today at

Moving forward, 2011 may be a rebounding year for many device makers hit hard by market conditions, competition and device recalls. Successful acquisition and restructuring efforts may help several companies in the industry resume growth this year. 

The two medical instruments & supplies stocks research reports are available for free by signing up now on


Shine's Room Online is the brain child of David Shine, a 15 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information